Markets & Stocks
Stock quotes, market indicators and the latest market news.
Market Summary Market News Stock Quotes Market MoversClimb Bio, Inc. - Common Stock (NQ:CLYM)
Price and Volume
Detailed Quote| Volume | 495,694 |
| Open | 10.47 |
| Bid (Size) | 10.08 (1,000) |
| Ask (Size) | 11.25 (400) |
| Prev. Close | 10.54 |
| Today's Range | 10.05 - 10.65 |
| 52wk Range | 1.635 - 18.33 |
| Shares Outstanding | 26,993,401 |
| Dividend Yield | N/A |
Top News
More News
Performance
52-Week Range
44.4% below 52-week high
10.19
1.6452W Low
18.3352W High
1 Week
9.5% below 1-week high
9.611W Low
11.261W High
Climb Bio, Inc. - Common Stock (CLYM) traded between $1.64 and $18.33 over the past 52 weeks and last traded at $10.19, 44.4% below its 52-week high. Over the past week it ranged between $9.61 and $11.26.
Past 12 Months
1W
+$0.46
1M
-$2.33
3M
-$2.65
6M
+$1.05
YTD
+$6.44
1Y
+$8.20
CLYM was +412.1% over the past year, +11.5% over six months, +171.7% year to date, +4.7% in the last week.
12 Months vs Market
CLYM
+412.1%
DIA
+11.6%
SPY
+13.1%
QQQ
+15.4%
IWM
+11.9%
Over the past 12 months CLYM returned +412.1% versus DIA (Dow) +11.6%, SPY (S&P 500) +13.1%, QQQ (Nasdaq 100) +15.4% and IWM (Russell 2000) +11.9%.
Volume & Liquidity
0.37× 3-mo avg
Today 495,694
3-mo avg 1.3M
1W
932.7K
1M
1.1M
3M
1.3M
6M
1.3M
YTD
1.0M
1Y
1.1M
CLYM most recently traded 495,694 shares against a 3-month average daily volume of 1.3M.
More News
Read More
Climb Bio Phase I Data Backs 12-Week Dosing Plan for IgA Nephropathy Drug ↗
September 03, 2026
Climb Bio to Present at Upcoming Investor Conferences
September 02, 2026
Climb Bio, Inc. Announces $110.0 Million Private Placement
April 28, 2026
Climb Bio to Present at Upcoming Investor Conferences
February 05, 2026
Unusual volume stocks in Tuesday's session ↗
December 16, 2025
Which stocks are moving on Monday? ↗
December 15, 2025
Monday's session: top gainers and losers ↗
December 15, 2025
Let's take a look at the stocks that are in motion in today's session. ↗
December 12, 2025
Climb Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
November 25, 2025
Frequently Asked Questions
Is Climb Bio, Inc. - Common Stock publicly traded?
Yes, Climb Bio, Inc. - Common Stock is publicly traded.
What exchange does Climb Bio, Inc. - Common Stock trade on?
Climb Bio, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Climb Bio, Inc. - Common Stock?
The ticker symbol for Climb Bio, Inc. - Common Stock is CLYM on the Nasdaq Stock Market
What is the current price of Climb Bio, Inc. - Common Stock?
The current price of Climb Bio, Inc. - Common Stock is 10.19
When was Climb Bio, Inc. - Common Stock last traded?
The last trade of Climb Bio, Inc. - Common Stock was at 10/23/26 04:00 PM ET
What is the market capitalization of Climb Bio, Inc. - Common Stock?
The market capitalization of Climb Bio, Inc. - Common Stock is 275.06M
How many shares of Climb Bio, Inc. - Common Stock are outstanding?
Climb Bio, Inc. - Common Stock has 275M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.